Bernaczyk P

No ORCID on file · 3 papers in corpus · active 2022-2025

Study types

  • article 1

Condition tags

  • adenomyosis 1
2025
Targeted destruction of follicle stimulating hormone receptor-positive cancer cells in vitro and in vivo by a lytic peptide Phor21-FSHβ conjugate.
Molecular medicine (Cambridge, Mass.) ·doi:10.1186/s10020-025-01292-5

BACKGROUND: Extragonadal follicle-stimulating hormone (FSH) receptor (FSHR) expression in various cancers and their endothelial vessel cells has highlighted novel opportunities for targeted FSHR therapy. METHODS: We investigated the specifi…

2024
Revisiting the follicle-stimulation hormone receptor expression and function in human myometrium and adipose tissue.
Molecular medicine (Cambridge, Mass.) ·doi:10.1186/s10020-024-01015-2

BackgroundExtragonadal follicle-stimulating hormone receptor (FSHR) expression at low levels has been shown in several normal and tumor tissues, including myometrium and adipose tissue. FSH-FSHR signaling in the myometrium has been suggeste…

article 2022
Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy
Journal of clinical medicine ·doi:10.3390/jcm11154407

Adenomyosis is a common gynaecological disease associated with the presence of endometrial lesions in the uterine myometrium. Estrogens have been proven to be the crucial hormones driving the growth of adenomyosis. Little is known about the…